Parkside Investments, LLC Bristol Myers Squibb CO Transaction History

Parkside Investments, LLC

$650 Million
Q3 2024

A detailed history of Parkside Investments, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Parkside Investments, LLC holds 18,000 shares of BMY stock, worth $1.03 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

18,000

Holding current value

$1.03 Million

% of portfolio

0.14%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$39.66 - $51.75 $713,879 - $931,500	18,000 New	18,000 $931,000
Q2 2022 Jul 13, 2022	SELL	$72.62 - $79.98 $2.03 Million - $2.24 Million	-27,967 Reduced 29.7%	66,188 $5.1 Million
Q1 2022 May 02, 2022	SELL	$61.48 - $73.72 $1.9 Million - $2.28 Million	-30,894 Reduced 24.71%	94,155 $6.88 Million
Q4 2021 Jan 18, 2022	BUY	$53.63 - $62.52 $696,331 - $811,759	12,984 Added 11.59%	125,049 $7.8 Million
Q3 2021 Oct 21, 2021	SELL	$59.17 - $69.31 $89,997 - $105,420	-1,521 Reduced 1.34%	112,065 $6.63 Million
Q2 2021 Jul 29, 2021	BUY	$61.91 - $67.42 $57,762 - $62,902	933 Added 0.83%	113,586 $7.59 Million
Q1 2021 Apr 14, 2021	BUY	$59.34 - $66.74 $1.34 Million - $1.51 Million	22,633 Added 25.14%	112,653 $7.11 Million
Q4 2020 Jan 13, 2021	BUY	$57.74 - $65.43 $598,070 - $677,723	10,358 Added 13.0%	90,020 $5.58 Million
Q3 2020 Oct 28, 2020	SELL	$57.43 - $63.64 $25,384 - $28,128	-442 Reduced 0.55%	79,662 $4.8 Million
Q2 2020 Jul 23, 2020	SELL	$54.82 - $64.09 $113,751 - $132,986	-2,075 Reduced 2.52%	80,104 $4.71 Million
Q1 2020 Apr 21, 2020	SELL	$46.4 - $67.43 $748,200 - $1.09 Million	-16,125 Reduced 16.4%	82,179 $4.58 Million
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $97,189 - $126,775	1,975 Added 2.05%	98,304 $6.31 Million
Q3 2019 Nov 06, 2019	BUY	$42.77 - $50.71 $310,082 - $367,647	7,250 Added 8.14%	96,329 $4.89 Million
Q2 2019 Aug 02, 2019	BUY	$44.62 - $49.34 $3.57 Million - $3.95 Million	80,075 Added 889.33%	89,079 $7.46 Million
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $180,480 - $215,200	4,000 Added 79.94%	9,004 $429,000
Q4 2018 Feb 04, 2019	SELL	$48.76 - $63.23 $146,084 - $189,437	-2,996 Reduced 37.45%	5,004 $260,000
Q3 2018 Oct 17, 2018	BUY	$55.19 - $62.25 $143,494 - $161,850	2,600 Added 48.15%	8,000 $496,000
Q2 2018 Aug 09, 2018	SELL	$50.53 - $62.98 $308,233 - $384,178	-6,100 Reduced 53.04%	5,400 $299,000
Q1 2018 May 11, 2018	BUY	$59.92 - $68.98 $509,320 - $586,330	8,500 Added 283.33%	11,500 $727,000
Q4 2017 Feb 07, 2018	BUY	$59.94 - $65.35 $179,820 - $196,049	3,000	3,000 $184,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $122B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Investments, LLC with notifications on news.

Account

Parkside Investments, LLC Bristol Myers Squibb CO Transaction History